WO2006003289A3 - Derives de polysaccharide sulfates pour moduler l’angiogenese - Google Patents

Derives de polysaccharide sulfates pour moduler l’angiogenese Download PDF

Info

Publication number
WO2006003289A3
WO2006003289A3 PCT/FR2005/001378 FR2005001378W WO2006003289A3 WO 2006003289 A3 WO2006003289 A3 WO 2006003289A3 FR 2005001378 W FR2005001378 W FR 2005001378W WO 2006003289 A3 WO2006003289 A3 WO 2006003289A3
Authority
WO
WIPO (PCT)
Prior art keywords
polysaccharide derivatives
modulating angiogenesis
sulphated polysaccharide
low
angiogenesis
Prior art date
Application number
PCT/FR2005/001378
Other languages
English (en)
Other versions
WO2006003289A2 (fr
Inventor
Sabine Matou
Sylvia Colliec-Jouault
Dominique Helley
Jacqueline Ratiskol
Corinne Sinquin
Claire Boisset
Jean Guezennec
Anne-Marie Fischer
Original Assignee
Ifremer
Univ Paris Descartes
Sabine Matou
Sylvia Colliec-Jouault
Dominique Helley
Jacqueline Ratiskol
Corinne Sinquin
Claire Boisset
Jean Guezennec
Anne-Marie Fischer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ifremer, Univ Paris Descartes, Sabine Matou, Sylvia Colliec-Jouault, Dominique Helley, Jacqueline Ratiskol, Corinne Sinquin, Claire Boisset, Jean Guezennec, Anne-Marie Fischer filed Critical Ifremer
Priority to US11/629,544 priority Critical patent/US7833990B2/en
Priority to EP20050775288 priority patent/EP1755620B1/fr
Priority to AU2005259077A priority patent/AU2005259077B2/en
Priority to CA 2570199 priority patent/CA2570199C/fr
Priority to JP2007515983A priority patent/JP5148272B2/ja
Priority to AT05775288T priority patent/ATE510546T1/de
Publication of WO2006003289A2 publication Critical patent/WO2006003289A2/fr
Publication of WO2006003289A3 publication Critical patent/WO2006003289A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0664—Dental pulp stem cells, Dental follicle stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0666—Mesenchymal stem cells from hair follicles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/72—Undefined extracts from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)

Abstract

La présente Invention est relative à l'utilisation de certains dérivés polysaccharidiques hautement sulfatés et de faible masse molaire obtenus à partir d'un polysaccharide d'origine bactérienne pour la préparation d'une composition pharmaceutique destinée à la modulation de l'angiogenèse, utilisable notamment pour accélérer la réparation de l'endothélium vasculaire lors d'accidents thrombotiques et ce avec un risque hémorragique faible.
PCT/FR2005/001378 2004-06-14 2005-06-06 Derives de polysaccharide sulfates pour moduler l’angiogenese WO2006003289A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US11/629,544 US7833990B2 (en) 2004-06-14 2005-06-06 Use of low-molecular-weight highly sulfated polysaccharide derivatives for modulating angiogenesis
EP20050775288 EP1755620B1 (fr) 2004-06-14 2005-06-06 Derives depolymerises sulfates d'exopolysaccharides (eps), preparation et leurs utilisations
AU2005259077A AU2005259077B2 (en) 2004-06-14 2005-06-06 Use of low-molecular-weight highly sulfated polysaccharide derivatives for modulating angiogenesis
CA 2570199 CA2570199C (fr) 2004-06-14 2005-06-06 Utilisation de derives de polysaccharide hautement sulfates et de faible masse molaire pour moduler l'angiogenese
JP2007515983A JP5148272B2 (ja) 2004-06-14 2005-06-06 血管新生を調節するための低分子量の高度に硫酸化された多糖誘導体の使用
AT05775288T ATE510546T1 (de) 2004-06-14 2005-06-06 Sulfierte depolymerisierte exopolysaccharidderivate, ihre herstellung und verwendungen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0406405 2004-06-14
FR0406405A FR2871379B1 (fr) 2004-06-14 2004-06-14 Utilisation de derives polysaccharidiques hautement sulfates et de faible masse molaire pour moduler l'angiogenese

Publications (2)

Publication Number Publication Date
WO2006003289A2 WO2006003289A2 (fr) 2006-01-12
WO2006003289A3 true WO2006003289A3 (fr) 2006-05-04

Family

ID=34946349

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/FR2005/001378 WO2006003289A2 (fr) 2004-06-14 2005-06-06 Derives de polysaccharide sulfates pour moduler l’angiogenese
PCT/FR2005/001379 WO2006003290A2 (fr) 2004-06-14 2005-06-06 Derives depolymerises sulfates d'exopolysaccharides (eps) preparation et utilisations

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/FR2005/001379 WO2006003290A2 (fr) 2004-06-14 2005-06-06 Derives depolymerises sulfates d'exopolysaccharides (eps) preparation et utilisations

Country Status (9)

Country Link
US (5) US20080131472A1 (fr)
EP (2) EP1755620B1 (fr)
JP (2) JP5148272B2 (fr)
AT (2) ATE510546T1 (fr)
AU (2) AU2005259078B2 (fr)
CA (2) CA2570199C (fr)
ES (2) ES2385088T3 (fr)
FR (1) FR2871379B1 (fr)
WO (2) WO2006003289A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894147B1 (fr) * 2005-12-07 2008-02-15 Ifremer Utilisation d'un polysaccharide excrete par l'espece vibrio diabolicus a des fins de regeneration et de protection du parodonte
JP2007204396A (ja) * 2006-01-31 2007-08-16 Pias Arise Kk マトリックスメタロプロテアーゼ−９及びエンドセリン−１の産生抑制剤、並びにその産生抑制剤を配合した炎症後色素沈着の予防・改善剤、化粧料
EP2265249B1 (fr) * 2008-04-15 2018-08-29 Lucas Meyer Cosmetics Canada Inc. Compositions cosmétiques comprenant des exopolysaccharides dérivés de tapis microbiens et utilisation de ces compositions
WO2010086696A1 (fr) 2009-01-28 2010-08-05 Therapol Polysaccharides sulfatés de faible masse moléculaire comme candidats pour une thérapie anti-angiogénique
FR2953217B1 (fr) 2009-11-27 2012-10-05 Ifremer Procede de depolymerisation de polysaccharides par broyage mecanique
CN101856658B (zh) * 2010-06-01 2011-09-07 云南大红山管道有限公司 一种长距离铁精矿管道软堵塞的疏通方法
FR2964014B1 (fr) * 2010-08-31 2013-04-05 Ifremer Nucleus enrobe d'un revetement filmogene aux proprietes antibacteriennes et cicatrisantes et procede d'obtention.
ES2390033B1 (es) 2010-11-30 2013-10-31 Lipotec S.A. Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas.
JP6100451B2 (ja) * 2011-01-18 2017-03-22 ヒノキ新薬株式会社 皮膚外用剤
ES2590752T3 (es) * 2011-03-18 2016-11-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Medios de diferenciación condrogénica y métodos para inducir la diferenciación condrogénica de células
ES2424294B1 (es) * 2012-03-22 2014-07-21 Lipotec, S.A. Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas
EP3146971A1 (fr) * 2015-09-28 2017-03-29 Institut Francais de Recherche pour l'Exploitation de la Mer (IFREMER) Dérivé d'exopolysaccharide bactérien marin anti-métastatique et leurs utilisations
CN109069875B (zh) * 2016-01-07 2021-12-24 位于本-古里安大学之内盖夫技术与应用有限公司 产生免疫耐受反应的组合物和方法
CA3035642A1 (fr) 2016-09-01 2018-03-08 Instituto De Biologia Molecular E Celular - Ibmc Polymere extracellulaire de cyanobacterie et leurs utilisations
JP2023533383A (ja) 2020-07-02 2023-08-02 アンスティテュ・フランセ・ドゥ・レシェルシェ・プール・レクスプローテシオン・ドゥ・ラ・メール （イエフエルウメール） 海洋性細菌性エキソポリサッカライド誘導体及びムコ多糖症の処置におけるその使用
EP4112060A1 (fr) 2021-07-01 2023-01-04 Institut Francais de Recherche pour l'Exploitation de la Mer (IFREMER) Dérivés d'exopolysaccharide he800 de faible poids moléculaire ayant des propriétés anticancéreuses et leurs utilisations
CN116731221B (zh) * 2023-06-26 2024-03-12 益得来(深圳)健康科技有限公司 一种多糖衍生物及其在制药中的用途

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2701488A1 (fr) * 1993-02-15 1994-08-19 Ifremer Bactéries du type Alteromonas, polysaccharides produits par ces bactéries, ose contenu dans ces polysaccharides et applications.
FR2755142A1 (fr) * 1996-10-30 1998-04-30 Ifremer Souche bacterienne marine du genre alteromonas, exopolysaccharides hydrosolubles produits par cette souche, et leurs utilisations
JPH10218902A (ja) * 1997-01-31 1998-08-18 Seikagaku Kogyo Co Ltd 低分子化硫酸化多糖、その製造法及び医薬組成物
WO1999067411A1 (fr) * 1998-06-22 1999-12-29 Institut Francais De Recherche Pour L'exploitation De La Mer (Ifremer) Polysaccharide purifie d'alteromonas macleodii et ses utilisations
WO2001015654A2 (fr) * 1999-09-01 2001-03-08 Institut Francais De Recherche Pour L'exploitation De La Mer (Ifremer) Polysaccharide antithrombotique de bas poids moleculaire
WO2003106506A1 (fr) * 2002-06-18 2003-12-24 Pasqua Anna Oreste Polysaccharide sursulfate de faible poids moleculaire

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4102566A (en) * 1977-05-02 1978-07-25 Foster Grant Corporation Rimless spectacle
JPS58121799A (ja) * 1982-01-14 1983-07-20 Microbial Chem Res Found 多糖類ｍｐ−８６物質およびその製造法
IT1214609B (it) 1985-05-17 1990-01-18 Opocrin Spa Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
US6255296B1 (en) * 1994-01-11 2001-07-03 Endomatrix, Inc. Composition and method for treating a patient susceptible to or suffering from a cardiovascular disorder or disease
JP2986376B2 (ja) * 1995-06-16 1999-12-06 株式会社ホリカワ リムレス眼鏡におけるブリッジ及びリムレス眼鏡
US5985330A (en) * 1996-08-05 1999-11-16 Coastside Bio Resources Inhibition of angiogenesis by sea cucumber fractions
US5828307A (en) * 1996-09-23 1998-10-27 Phillips Petroleum Company Hydrocarbon gas monitor desk
US5847800A (en) * 1996-12-13 1998-12-08 Tachibana; Hideaki Lens holding mechanism of spectacles
FR2760022B1 (fr) 1997-02-25 1999-04-30 Ifremer Souche bacterienne marine du genre vibrio, polysaccharides hydrosolubles produits par cette souche, et leurs utilisations
US6024445A (en) * 1998-11-04 2000-02-15 Microvision Optical, Inc. Single point attachment of bridge and temples to eyeglass lenses
IT1302534B1 (it) * 1998-12-21 2000-09-05 Fidia Advanced Biopolymers Srl Composizioni iniettabili, biocompatibili e biodegradabili comprendentialmeno un derivato dell'acido ialuronico, cellule condrogeniche, per
FR2811229B1 (fr) * 2000-07-04 2003-08-01 Ifremer Utilisation d'un polysaccharide excrete par l'espece vibrio diabolicus en cicatrisation osseuse
US7736636B2 (en) * 2003-02-12 2010-06-15 Shaker Mousa Method for treating occlusive vascular diseases & wound healing

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2701488A1 (fr) * 1993-02-15 1994-08-19 Ifremer Bactéries du type Alteromonas, polysaccharides produits par ces bactéries, ose contenu dans ces polysaccharides et applications.
FR2755142A1 (fr) * 1996-10-30 1998-04-30 Ifremer Souche bacterienne marine du genre alteromonas, exopolysaccharides hydrosolubles produits par cette souche, et leurs utilisations
JPH10218902A (ja) * 1997-01-31 1998-08-18 Seikagaku Kogyo Co Ltd 低分子化硫酸化多糖、その製造法及び医薬組成物
WO1999067411A1 (fr) * 1998-06-22 1999-12-29 Institut Francais De Recherche Pour L'exploitation De La Mer (Ifremer) Polysaccharide purifie d'alteromonas macleodii et ses utilisations
WO2001015654A2 (fr) * 1999-09-01 2001-03-08 Institut Francais De Recherche Pour L'exploitation De La Mer (Ifremer) Polysaccharide antithrombotique de bas poids moleculaire
WO2003106506A1 (fr) * 2002-06-18 2003-12-24 Pasqua Anna Oreste Polysaccharide sursulfate de faible poids moleculaire

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
COLLIEC JOUAULT A S ET AL: "Characterization, chemical modifications and in vitro anticoagulant properties of an exopolysaccharide produced by Alteromonas infernus", BBA - GENERAL SUBJECTS, ELSEVIER SCIENCE PUBLISHERS, NL, vol. 1528, no. 2-3, 3 October 2001 (2001-10-03), pages 141 - 151, XP004312011, ISSN: 0304-4165 *
DATABASE WPI Section Ch Week 199843, Derwent World Patents Index; Class B04, AN 1998-501676, XP002368826 *
GUEZENNEC J ET AL: "Sulfation and depolymerization of a bacterial exopolysaccharide of hydrothermal origin", CARBOHYDRATE POLYMERS, APPLIED SCIENCE PUBLISHERS, LTD. BARKING, GB, vol. 37, no. 1, September 1998 (1998-09-01), pages 19 - 24, XP004141130, ISSN: 0144-8617 *
ZUBKOV V A ET AL: "Structure of the capsular polysaccharide from Alteromonas sp. CMM 155", CARBOHYDRATE RESEARCH, ELSEVIER SCIENTIFIC PUBLISHING COMPANY. AMSTERDAM, NL, vol. 275, no. 1, 15 September 1995 (1995-09-15), pages 147 - 154, XP004021934, ISSN: 0008-6215 *

Also Published As

Publication number Publication date
WO2006003290A3 (fr) 2006-05-04
ES2385088T3 (es) 2012-07-18
AU2005259078A2 (en) 2006-01-12
US20080131472A1 (en) 2008-06-05
CA2570224A1 (fr) 2006-01-12
FR2871379B1 (fr) 2006-09-29
AU2005259078A1 (en) 2006-01-12
ATE510546T1 (de) 2011-06-15
ES2367121T3 (es) 2011-10-28
US8598142B2 (en) 2013-12-03
EP1765366B1 (fr) 2012-01-11
EP1755620A2 (fr) 2007-02-28
FR2871379A1 (fr) 2005-12-16
JP5148272B2 (ja) 2013-02-20
US20070259833A1 (en) 2007-11-08
AU2005259078B2 (en) 2011-03-31
US7833990B2 (en) 2010-11-16
EP1755620B1 (fr) 2011-05-25
EP1765366A2 (fr) 2007-03-28
US20110245199A1 (en) 2011-10-06
AU2005259077A1 (en) 2006-01-12
WO2006003290A2 (fr) 2006-01-12
JP2008502762A (ja) 2008-01-31
JP5154221B2 (ja) 2013-02-27
AU2005259077B2 (en) 2011-01-20
JP2008502763A (ja) 2008-01-31
US20140037597A1 (en) 2014-02-06
CA2570199A1 (fr) 2006-01-12
CA2570199C (fr) 2013-08-06
ATE540685T1 (de) 2012-01-15
US9125883B2 (en) 2015-09-08
US20150344848A1 (en) 2015-12-03
WO2006003289A2 (fr) 2006-01-12
CA2570224C (fr) 2015-08-04
US10105393B2 (en) 2018-10-23

Similar Documents

Publication Publication Date Title
WO2006003289A3 (fr) Derives de polysaccharide sulfates pour moduler l’angiogenese
WO2019075263A3 (fr) Procédés et compositions à administration topique
EP2256175A3 (fr) Compositions d'ethers d'hydrates de carbone cationiques viscoelastiques
WO2007057714A3 (fr) Compositions pharmaceutiques
WO2010068864A3 (fr) Polyesters présentant des zwitterions greffés
WO2009027957A3 (fr) Systèmes de parfums
WO2004078120A3 (fr) Compositions et biomateriaux de collagene
WO2007127668A3 (fr) Nouveaux procedes de revetement d'un contenant empechant la precipitation de formulations de conjugues de polysaccharide-proteine
DK1841332T3 (da) Fortykningskomposition til dysfagi patienter
WO2004093795A3 (fr) Compositions d'administration de combinaisons de medicaments
WO2005092272A8 (fr) Produits en film presentant des proprietes de desintegration commandee
NZ597154A (en) Immunogenic compositions of staphylococcus aureus antigens
WO2006119498A3 (fr) Compositions pharmaceutiques avec liberation synchronisee de l'agent solubilisant
EP1992645A4 (fr) Nouvel acide hyaluronique a faible poids moleculaire et/ou sel de celui-ci, et preparation cosmetique, composition pharmaceutique et composition alimentaire chacune utilisant ledit acide
WO2007146416A3 (fr) Préparations de glycane
WO2003011226A3 (fr) Produits et excipients pour l'administration de medicaments
WO2007144644A3 (fr) Composition de matrice extracellulaire
EP1561760A3 (fr) Sel triéthanolamine d'une héparine de faible poids moléculaire
WO2009094361A3 (fr) Polymères conjugués de 3,4-propylènedioxythiophène substitué, leur composition, leur procédé de fabrication et leur utilisation
WO2007125105A3 (fr) Activateurs de la glucokinase benzamidique
ZA200707973B (en) Low amounts of high molecular weight polymer for enhancing viscosity of aqueous/aqueous biphasic liquids
WO2004082634A3 (fr) Polymeres et oligomeres a surface amphiphile et leurs utilisations
WO2006019955A3 (fr) Methodes et compositions antivirales
WO2009059755A3 (fr) Nouveaux conjugués de neurturine pour une utilisation pharmaceutique
WO2008062467A3 (fr) Mélanocytes cultivés sur biopolymères

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11629544

Country of ref document: US

Ref document number: 2007515983

Country of ref document: JP

Ref document number: 2570199

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2005775288

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 2005259077

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2005259077

Country of ref document: AU

Date of ref document: 20050606

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005259077

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2005775288

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 11629544

Country of ref document: US